Literature DB >> 27075827

Novel risk stratification and treatment.

Takaaki Komatsu1, Shiro Nakahara1, Isao Taguchi1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27075827     DOI： 10.1038/hr.2016.39

Source DB:  PubMed          Journal:  Hypertens Res        ISSN： 0916-9636            Impact factor:   3.872


× No keyword cloud information.
  11 in total

1.  Neutrophil infiltration of culprit lesions in acute coronary syndromes.

Authors:  Takahiko Naruko; Makiko Ueda; Kazuo Haze; Allard C van der Wal; Chris M van der Loos; Akira Itoh; Ryushi Komatsu; Yoshihiro Ikura; Masayuki Ogami; Yoshihisa Shimada; Shoichi Ehara; Minoru Yoshiyama; Kazuhide Takeuchi; Junichi Yoshikawa; Anton E Becker
Journal:  Circulation       Date:  2002-12-03       Impact factor: 29.690

2.  Which white blood cell subtypes predict increased cardiovascular risk?

Authors:  Benjamin D Horne; Jeffrey L Anderson; Jerry M John; Aaron Weaver; Tami L Bair; Kurt R Jensen; Dale G Renlund; Joseph B Muhlestein
Journal:  J Am Coll Cardiol       Date:  2005-04-25       Impact factor: 24.094

3.  Plasma homocyst(e)ine levels in men with premature coronary artery disease.

Authors:  J J Genest; J R McNamara; D N Salem; P W Wilson; E J Schaefer; M R Malinow
Journal:  J Am Coll Cardiol       Date:  1990-11       Impact factor: 24.094

4.  Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality: insights from the National Health and Nutrition Examination Survey-III.

Authors:  Neeraj Shah; Valay Parikh; Nileshkumar Patel; Nilay Patel; Apurva Badheka; Abhishek Deshmukh; Ankit Rathod; James Lafferty
Journal:  Int J Cardiol       Date:  2013-12-23       Impact factor: 4.164

5.  Early urinary biomarkers for renal tubular damage in spontaneously hypertensive rats on a high salt intake.

Authors:  Keiko Hosohata; Daisuke Yoshioka; Akira Tanaka; Hitoshi Ando; Akio Fujimura
Journal:  Hypertens Res       Date:  2015-09-17       Impact factor: 3.872

6.  Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome.

Authors:  Gideon R Hajer; Yolanda van der Graaf; Jobien K Olijhoek; Marianne C Verhaar; Frank L J Visseren
Journal:  Heart       Date:  2006-09-04       Impact factor: 5.994

7.  Renal inflammatory markers during the onset of hypertension in spontaneously hypertensive rats.

Authors:  Bart Fj Heijnen; Helma Van Essen; Casper G Schalkwijk; Ben Ja Janssen; Harry Aj Struijker-Boudier
Journal:  Hypertens Res       Date:  2013-08-29       Impact factor: 3.872

8.  Low-dose colchicine for secondary prevention of cardiovascular disease.

Authors:  Stefan M Nidorf; John W Eikelboom; Charley A Budgeon; Peter L Thompson
Journal:  J Am Coll Cardiol       Date:  2012-12-19       Impact factor: 24.094

9.  Angiotensin AT2 receptor stimulation is anti-inflammatory in lipopolysaccharide-activated THP-1 macrophages via increased interleukin-10 production.

Authors:  Isha Dhande; Wanshu Ma; Tahir Hussain
Journal:  Hypertens Res       Date:  2014-09-11       Impact factor: 3.872

10.  Increased neutrophil to lymphocyte ratio in persons suffering from hypertension with hyperhomocysteinemia.

Authors:  Li Gang; Zhang Yanyan
Journal:  Hypertens Res       Date:  2016-03-24       Impact factor: 3.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.